Company · CIK 1740279
IN8BIO, INC.
| CIK | 1740279 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | NY |
| Listed | INAB (Nasdaq) |
| First annual or quarterly report | 2021-09-10 |
Offerings
7 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-291393 | 2025-11-07 | 2026-06-01 | 3 | |
| 333-292830 | 2026-01-20 | 2026-01-28 | 2 | |
| 333-282984 | 2024-11-04 | 2024-11-12 | 2 | |
| 333-268288 | 2022-11-10 | 2024-08-12 | 8 | |
| 333-276504 | 2024-01-12 | 2024-01-18 | 2 | |
| 333-266620 | 2022-08-08 | 2022-08-15 | 4 | |
| 333-249530 | 2020-10-16 | 2021-07-30 | 8 |
Filings
31| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-01 | 424B5Shelf takedown | 333-291393 | 0001193125-26-249564 |
| 2026-05-19 | EFFECTDeclared effective | 333-291393 | 9999999995-26-001697 |
| 2026-01-28 | EFFECTDeclared effective | 333-292830 | 9999999995-26-000335 |
| 2026-01-20 | S-3Shelf registered | 333-292830 | 0001193125-26-016752 |
| 2025-11-07 | S-3Shelf registered | 333-291393 | 0001193125-25-272565 |
| 2024-11-12 | EFFECTDeclared effective | 333-282984 | 9999999995-24-003468 |
| 2024-11-04 | S-3Shelf registered | 333-282984 | 0001193125-24-250651 |
| 2024-08-12 | 424B5Shelf takedown | 333-268288 | 0001193125-24-198987 |
| 2024-05-07 | 424B5Shelf takedown | 333-268288 | 0001193125-24-133090 |
| 2024-01-18 | EFFECTDeclared effective | 333-276504 | 9999999995-24-000152 |
| 2024-01-12 | S-3Shelf registered | 333-276504 | 0001193125-24-007652 |
| 2023-07-31 | 424B5Shelf takedown | 333-268288 | 0001193125-23-199189 |
| 2023-07-14 | 424B5Shelf takedown | 333-268288 | 0001193125-23-187357 |
| 2023-04-27 | 424B5Shelf takedown | 333-268288 | 0001193125-23-122442 |
| 2023-04-26 | 424B5Shelf takedown | 333-268288 | 0001193125-23-116946 |
| 2022-11-21 | EFFECTDeclared effective | 333-268288 | 9999999995-22-003364 |
| 2022-11-10 | S-3Shelf registered | 333-268288 | 0001193125-22-282064 |
| 2022-08-15 | 424B4Final prospectus | 333-266620 | 0001193125-22-220140 |
| 2022-08-11 | EFFECTDeclared effective | 333-266620 | 9999999995-22-002350 |
| 2022-08-09 | S-1/AAmendment | 333-266620 | 0001193125-22-215740 |
| 2022-08-08 | S-1Registration filed | 333-266620 | 0001193125-22-214130 |
| 2022-07-20 | DRSDraft made public | 377-06280 | 0000950123-22-007291 |
| 2021-07-30 | 424B4Final prospectus | 333-249530 | 0001104659-21-098288 |
| 2021-07-29 | EFFECTDeclared effective | 333-249530 | 9999999995-21-002969 |
| 2021-07-22 | S-1/AAmendment | 333-249530 | 0001104659-21-094684 |
| 2021-07-20 | S-1/AAmendment | 333-249530 | 0001104659-21-093677 |
| 2021-05-07 | S-1/AAmendment | 333-249530 | 0001104659-21-063186 |
| 2021-03-31 | S-1/AAmendment | 333-249530 | 0001104659-21-044928 |
| 2020-11-05 | S-1/AAmendment | 333-249530 | 0001104659-20-121840 |
| 2020-10-16 | S-1Registration filed | 333-249530 | 0001104659-20-115697 |
| 2020-09-10 | DRSDraft made public | 377-03527 | 0001104659-20-104010 |